Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
JHL Biotech
Pharma
Sumitomo-Myovant, Astellas-Taysha, Genentech—Fierce Pharma Asia
Sumitomo pays $1.7 billion to acquire Myovant. Astellas invests in Taysha Gen Therapies. A couple gets six-month prison time in trade secret case.
Angus Liu
Oct 28, 2022 9:15am
Ex-Genentech staffer, husband sentenced in trade secrets case
Oct 24, 2022 11:37am
Bora's newest CDMO plant comes from troubled compatriot Eden
May 13, 2022 10:59am
Two JHL execs are headed to prison for stealing Genentech info
Mar 16, 2022 10:42am
Moderna, Astellas, Takeda and more—Fierce Pharma Asia
Sep 3, 2021 10:26am
Biotech co-founders admit to stealing secrets from Genentech
Aug 30, 2021 10:40am
